Curaleaf Holdings (CURLF) Profit After Tax (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Profit After Tax of $69.8 million in Q1 2026, up 100.12% quarter-over-quarter from -$57.6 billion in Q4 2025, and up 215.83% on a YoY basis from $22.1 million in Q1 2025.
Curaleaf Holdings (CURLF) Profit After Tax (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Profit After Tax history runs 8 years deep, the most recent figure standing at $69.8 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 215.83% year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at -$111.2 billion (down 47985.15% YoY), while the FY2025 annual figure was -$201.9 million, up 9.06% from the prior year.
- Profit After Tax was $69.8 million for Q1 2026 at Curaleaf Holdings, up from -$57.6 billion in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $69.8 million in Q1 2026 to a low of -$65.6 billion in Q4 2023.
- Historically, Profit After Tax has averaged -$10.4 billion across 5 years, with a median of -$56.7 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Profit After Tax slumped 107477.76% in 2025, then jumped 215.83% in 2026.
- A 5-year view of Profit After Tax shows it stood at -$262.7 million in 2022, then plunged by 24884.68% to -$65.6 billion in 2023, then soared by 99.88% to -$78.5 million in 2024, then slumped by 73322.71% to -$57.6 billion in 2025, then soared by 100.12% to $69.8 million in 2026.
- The last three Profit After Tax figures came in at $69.8 million (Q1 2026), -$57.6 billion (Q4 2025), and -$56.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.36 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | 69.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.78 Mn |
| Dec 31, 2025 | -57.62 Bn |
| Sep 30, 2025 | -56.68 Mn |
| Jun 30, 2025 | -53.61 Bn |
| Mar 31, 2025 | -60.25 Mn |
| Dec 31, 2024 | -78.47 Mn |
| Sep 30, 2024 | -42.73 Mn |
| Jun 30, 2024 | -49.83 Mn |
| Mar 31, 2024 | -51.01 Mn |
| Dec 31, 2023 | -65.65 Bn |
| Sep 30, 2023 | -93.73 Mn |
| Jun 30, 2023 | -74.49 Mn |
| Mar 31, 2023 | -3.15 Mn |
| Dec 31, 2022 | -262.75 Mn |
| Sep 30, 2022 | -54.16 Mn |
| Jun 30, 2022 | -21.76 Mn |
| Mar 31, 2022 | 21.76 Mn |
| Dec 31, 2021 | -75.50 Mn |
| Sep 30, 2021 | 57.67 Mn |
| Jun 30, 2021 | 8.28 Mn |